FDA Investigator Stacey S Degarmo

Stacey S Degarmo has inspections in 6 countries as of 13 Oct 2023. Stacey S Degarmo has collaborated with a combinined 5125 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Belgium, United States of America, Malta, India, Denmark, Canada
Co-Investigator(s):
Abby E Pelletier, Abdur Rafay Shareef, Ademola O Daramola, Aimee Cunningham, PhD, Aireen V Mendoza, Alan R Condon, Alice C Silva, Alice Canty, Allison A Rodriguez, Almaris N Alonso, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Amy N Chen, Anastasia M Shields, Andre S Lamontagne, Andrew Le, Andrew M Barlow, Angela E Glenn, Angela J Davis, Anissa M Cheung, Anne E Carpenter, Annet R Rajan, Anthony C Warchut, Anthony W Thomas, Arie C Menachem, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashley M Whitehurst, Barbara M Frazier, Bo Chi, PhD, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brentley S Collins, Brently S Collins, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Camerson E Moore, Candace Y Gomez Broughton, Carla C Cummins, Carla C Tuite, Carlos Chavez, Cassandra L Abellard, Charanjeet Jassal, Charlotte Hinkle, Cheryl A Clausen, Chiang Syin, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christopher Downey, PhD, Constance Desimone, Courtney N Long, Crystal Monroy, Cynthia A Palmer, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel L Zheng, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, David Van Houten, Dawn M Braswell, Deborah J Parris, Demitria J Xiradakis, Dien N Nguyen, Donald C Obenhuber, PhD, Dorothy W Lee, Douglas Florentino, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Ekaterina Allen, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Erik M Koester, Erik W Koester, Felix Maldonado, Garry H Stewart, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Gerard D Difiore, Gunther Bockhoudt, Gunther Boekhoudt, PhD, Helen B Ricalde, Helen Verdel, Holly Brevig, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Liubicich, James W Whitney, Jamie S Mathews, Jason A Rossi, Javier O Vega, Jawaid Hamid, Jayaleka J Amarasinghe, Jee Chung, PhD, Jennifer C Adams, Jennifer T Szymanski, Jianming Li, Joan A Loreng, John A Sciacchitano, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose E Melendez, DDC, Jose R Hernandez, Joyce A Kellett, Joyce A Rockwell, Julie D Bringger, Jun Park, PhD, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Kara D Dobbin, Karen A Briggs, Karen Mcnabb Noon, Katherine D Adams, Kathleen E Mcafoose, Kathleen R Jones, PhD, Katie L Korchinski, Kenneth H Williams, Kent A Conforti, Kristina J Donohue, Kristina M Joyce, L Norwood, Lane V Christensen, PhD, Larry K Austin, Lauren M Lawrance, Laurie B Frazier, Laurie Graham, Lawrence J Stringer, LCDR Debra Emerson, Lei Zhang, PhD, Leiyun Boone, PhD, Leo B Zadecky, Li Yun Huang, Lori A Holmquist, Lori M Newman, Louis Christy, M Pedgen, Maotang Zhou, PhD, Margaret E Walsh, Margaret M Sands, Maria Joselopez Barragan, PhD, Marie F Morin, Mariza M Jafary, Mark C Lookabaugh, Mark E Parmon, Mark R Mcclain, Marlene G Swider, Martha T Olone, Mary Jeanet Mcgarry, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Maura Rooney, Maxwell Van Tassell, PhD, Maya M Davis, Megan A Haggerty, Megan A, Haggerty, Michael J Casey, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Forster, PhD, Michelle M Noe, Michelle Y Clark Stuart, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Monique C Lo, Mra Greenc, Nabil Nakhoul, Nailing Zhang, Nancy T Waites, Nealie C Newberger, Nicholas B Murphy, Nichole B Murphy, Nicole K Trudel, Obinna R Echeozo, Osama A Khatib, Pal S Mayasandra, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia Fhughes Troost, Paul L Bellamy, Paul Mouris, Paul P Geraci, Paula A Trost, Paula M Laplant, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, Qing Joanna Zhou, PhD, Raeann R Wu, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard A Abate, Richard B Mcaroy, Richard H Penta, Richard L Friedman, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert D Tollefsen, Robert J Doyle, Robert J Martin, Robert Mo Brien, Rory K Geyer, Rose M Ashley, S Lori Brown, PhD MPH, Saleem A Akhtar, Samuel J Arsenault, Sandra A Hughes, Sandra P White, Sangeeta M Khurana, PhD, Satheesh Thomas, Scott R Nichols, PhD, Sean R Bryd, Sean R Marcsisin, Seth A Mailhot, Sharon K Thoma, PharmD, Shirley S Wen, Simone E Pitts, Slater K Bartlett, State Agency, Stephen C King, Stephen C Smith, Stephen J Mottola, Stephen R Souza, Steven Fong, MS, PhD, Steven P Donald, Sunita Pandey, Susan D Yuscius, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Sylvia A Craven, Teddy Tom, Thomas J Arista, Thomas W Nerney, Tonia F Bernard, Towanda L Terrell, Valentino Fiorella, Victor J Gangi, Victoria M Daddeo, Walter Lange, Wayne E Seifert, Wendy A Johnecheck, William Hallett, PhD, William J Leonard, Xiaokuang Lai, PhD, Yanming An, PhD, Yetao Jin, PhD, Ying Xin Fan, PhD, Yumi J Hiramine, Ze Peng, Zhihao Qiu (Peter), PhD, Zhongren Wu, Ziyang Su, PhD

Stacey S Degarmo's Documents

Publish Date Document Type Title
June, 2016 FDA 483 Avista Pharma Solutions, Inc. dba Cambrex - Form 483, 2016-06-15
June, 2016 FDA 483 Response Avista Pharma Solutions, Inc. dba Cambrex - Form 483R, 2016-10-04
January, 2013 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2013-01-29
April, 2010 FDA 483 Lonza Biologics, Inc. - Form 483, 2010-04-21
March, 2014 EIR NYPRO Finpack Clinton - EIR, 2014-03-21
September, 2011 FDA 483 CIPLA LIMITED - Form 483, 2011-09-22
March, 2015 FDA 483 DANIPHARM A/S - Form 483, 2015-03-04
August, 2015 FDA 483 Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - Form 483, 2015-08-28
June, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-06-02
February, 2016 FDA 483 Response Anderson Holdings Inc. - Form 483R, 2016-02-29
August, 2011 EIR AMAG Pharmaceuticals, Inc. - EIR, 2011-08-03
September, 2016 FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2016-09-30
February, 2016 FDA 483 Anderson Holdings Inc. - Form 483, 2016-02-19
September, 2014 FDA 483 Response Northern New England Compounding Pharmacy LLC - Form 483R, 2015-04-22
April, 2014 FDA 483 PLZ Corp - Form 483, 2014-06-04
September, 2013 EIR Genzyme Corporation - EIR, 2013-09-30
March, 2014 FDA 483 NYPRO Finpack Clinton - Form 483, 2014-03-21
June, 2015 FDA 483 AbbVie Bioresearch Center - Form 483, 2015-06-11
August, 2014 FDA 483 PHARMARON MANUFACTURING SERVICES (US) LLC - Form 483, 2014-08-15
March, 2016 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2016-03-25
February, 2012 FDA 483 Bayscience Formulators, LLC - Form 483, 2012-02-29
October, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-10-22
August, 2011 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2011-08-03
July, 2014 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2014-07-10
January, 2010 FDA 483 The Gillette Company - Form 483, 2010-01-29
December, 2011 FDA 483 Citra Labs, LLC - Form 483, 2011-12-09
September, 2011 FDA 483 Aurobindo Pharma Limited - Form 483, 2011-09-08
January, 2014 FDA 483 Lyophilization Services Of New England, Inc. (LSNE) - Form 483, 2014-01-29
April, 2011 FDA 483 Sunovion Pharmaceuticals Inc. - Form 483, 2011-04-20
July, 2016 FDA 483 Curia Massachusetts, Inc. - Form 483, 2016-07-13
September, 2014 FDA 483 Northern New England Compounding Pharmacy LLC - Form 483, 2014-09-30
July, 2010 EIR Ameridose, LLC - EIR, 2010-07-15
January, 2013 FDA 483 BFS Pharma, Inc. - Form 483, 2013-01-17
July, 2010 EIR Ameridose, LLC - EIR, 2010-07-08
April, 2015 EIR Lyophilization Services Of New England, Inc. (LSNE) - EIR, 2015-04-24
August, 2012 FDA 483 Tender Corporation - Form 483, 2012-08-17
September, 2010 EIR Biogen, Inc. - EIR, 2010-09-08
June, 2015 EIR AbbVie Bioresearch Center - EIR, 2015-06-11
October, 2012 FDA 483 New England Compounding Pharmacy, Inc. - Form 483, 2012-10-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more